Buserelin (CAS 57982-77-1) Suppliers and Product Information

Buserelin is a synthetic peptide hormone used primarily in the treatment of prostate cancer and endometriosis. It is also used for other indications such as premenopausal breast cancer, uterine fibroids, early puberty, assisted reproduction for female infertility, and as part of transgender hormone therapy. The medication is typically administered as a nasal spray three times a day but is also available as a solution or implant for injection.

Frequently Asked Questions

Q: What are the main uses of Buserelin?

A: Buserelin is primarily used for treating advanced prostate cancer and endometriosis. It is also used in assisted reproduction, treatment of premenopausal breast cancer, uterine fibroids, and early puberty.

Q: How is Buserelin administered?

A: Buserelin is typically administered as a nasal spray three times daily. It is also available as a solution or implant for injection.

Q: What are the potential side effects of Buserelin?

A: Common side effects may include weakness, nervousness, dizziness, nausea, headache, hot flushes, stomach pain, swelling of the legs, and breast pain. At the injection site, there may be pain, bleeding, or hardening of the skin.

Q: How should Buserelin be stored?

A: Buserelin should be stored at 4°C (39.2°F).